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Abstract

Received: October 1, 2021

We present a methodology for subtyping of persons with a common clinical symptom complex by integrating heterogeneous continuous and categorical data. We illustrate it by clustering women with lower urinary tract symptoms (LUTS), who represent a heterogeneous
cohort with overlapping symptoms and multifactorial etiology. Data collected in the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN), a multi-center observational study, included self-reported urinary and non-urinary symptoms, bladder diaries,
and physical examination data for 545 women. Heterogeneity in these multidimensional
data required thorough and non-trivial preprocessing, including scaling by controls and
weighting to mitigate data redundancy, while the various data types (continuous and categorical) required novel methodology using a weighted Tanimoto indices approach. Data
domains only available on a subset of the cohort were integrated using a semi-supervised
clustering approach. Novel contrast criterion for determination of the optimal number of clusters in consensus clustering was introduced and compared with existing criteria. Distinctiveness of the clusters was confirmed by using multiple criteria for cluster quality, and by
testing for significantly different variables in pairwise comparisons of the clusters. Cluster
dynamics were explored by analyzing longitudinal data at 3- and 12-month follow-up. Five
clusters of women with LUTS were identified using the developed methodology. None of the
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Subtyping complex disorders by clustering heterogeneous data

clusters could be characterized by a single symptom, but rather by a distinct combination of
symptoms with various levels of severity. Targeted proteomics of serum samples demonstrated that differentially abundant proteins and affected pathways are different across the
clusters. The clinical relevance of the identified clusters is discussed and compared with the
current conventional approaches to the evaluation of LUTS patients. The rationale and
thought process are described for the selection of procedures for data preprocessing, clustering, and cluster evaluation. Suggestions are provided for minimum reporting requirements in publications utilizing clustering methodology with multiple heterogeneous data
domains.

Competing interests: The authors have declared
that no competing interests exist.

Introduction
Complex diseases, such as obesity, diabetes, atherosclerosis, Alzheimer’s disease, major depressive disorder, and cancer result from multiple genetic, epigenetic, and environmental factors,
and importantly, interactions between these factors [1–3]. Important differences between
patients with these complex diseases and disorders may exist at multiple levels, including: (a)
symptoms, subjective experiences, and adaptive behaviors; (b) characteristics of the physical
state of the organism, including comorbidities; (c) characteristics of organs and systems; and
(d) characteristics at the cellular or molecular level. The extent of these differences suggests
that some complex diseases, disorders, and symptom complexes are better represented by subtypes, each of which can potentially have different etiologies, mechanisms, and outcomes, and
require different approaches to treatment. Subtype identification is therefore a potentially
important aspect to understanding and treating complex diseases and disorders. Specifically,
extracting patient characteristics at each level and grouping patients based on these characteristics allows for comprehensive clinical phenotyping and provides necessary information for
discovery and implementation of personalized treatments. Characteristics at each level are represented by variables of different types (continuous, categorical, and binary), scales, and different level of relevance or impact for the disease of interest. This data heterogeneity requires
thoughtful preprocessing and novel approaches to data integration.
Lower urinary tract symptoms (LUTS) is a general term representing a heterogeneous
group of symptoms or symptom complex with sometimes unclear etiology, high economic
and social costs, and significant effects on patients’ quality of life. LUTS can include frequent
urination during day and night (nocturia), urinary urgency (a sudden urge to urinate), stress
and urgency urinary incontinence (UI), and bladder emptying symptoms such as straining,
hesitancy (delay to start to urinate), weak urine stream, and post-void dribbling. None of the
symptoms is pathognomonic for a particular diagnosis, and many persons have more than one
symptom. The prevalence of LUTS in the United States (US) ranges between 45% and 70%
and increases with age [4,5]. Given the aging population in the US, the prevalence of LUTS is
expected to increase in the coming years [6]. Medical expenditures for LUTS have been
reported to be as high as $65 billion per year [7], yet many therapeutic options for the treatment of LUTS do not provide long-term symptom relief. Many patients experience a combination of symptoms, so treatment that focuses on a single symptom may result in suboptimal
care. To improve treatment outcomes for patients with LUTS, it is necessary to sort out the
heterogeneity of this population, increase the understanding of different subtypes of LUTS
and their underlying mechanisms.
One way to better understand a complex disease, disorder, or symptom complex is to use
an unbiased, data-driven unsupervised clustering approach to identify subtypes of individuals
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with the disease. This method uses data to identify groups, or clusters, such that members of
each cluster are as similar as possible to others within their cluster, but as different as possible
from those in other clusters [8]. Subtypes identified in this manner are based on similarities
and differences within the data, remaining agnostic to clinical definitions or diagnostic
categories.
Clustering methodologies have generated important contributions to the analysis of healthrelated data and are becoming increasingly valuable tools as the field of precision medicine
progresses. These methods represent a burgeoning field of research [9–15]. Many unsupervised classification or clustering methods have been developed, from commonly used k-means
clustering, hierarchical clustering, and self-organizing maps (SOM) [16–18] to algorithms
developed in specific areas for specific applications [19–21]. An important problem in unsupervised clustering is determining the optimal number of clusters. Currently available criteria
include Calinski-Harabasz, Davies-Bouldin, Dunn, Gap, Silhouette indices, and others [22–
26]; however, the optimal number of clusters may vary by the criterion applied. Therefore,
another critical issue is to validate the clustering results, that is, to gain confidence about the
clinical significance of the putative clusters, both in terms of cluster numbers and cluster
assignments.
Disease subtyping by clustering “-omics” data of certain types, mostly gene expression data,
has been extensively published [27–30]. More recent studies have subtyped complex diseases
by clustering heterogeneous data that included patient health questionnaires and other clinical
data. These research studies include subtyping asthma by using questionnaires, physiological
tests, and lab tests [31]; subtyping type 2 diabetes by using body mass index (BMI), age at
onset of diabetes, homoeostasis model assessment estimates, and insulin resistance [32]; and
subtyping sepsis using demographics, vital signs, biomarkers of inflammation, and organ dysfunction or injury [33].
Resampling based consensus clustering initially proposed for clustering gene expression
data [34] is gaining popularity and has been used for subtyping complex diseases using heterogeneous data [33,35]. Multiple random resampling of patients followed by k-means clustering
generates probabilities that each pair of patients appear in the same cluster, which can be
treated as a pairwise distance between patients and used for determination of cluster membership through hierarchical clustering [34]. This method ensures the clustering results are robust
to sampling errors.
Previous studies aiming to identify subtypes of LUTS in an unbiased manner include Epidemiology Urinary Incontinence and Comorbidities (EPIC) and Boston Area Community
Health (BACH) projects [36,37], which performed clustering of LUTS patients based on a relatively small number of self-reported symptom data in community-dwelling cohorts. Another
study used only BMI and bladder diary variables for clustering community-dwelling women
with LUTS [38].
The Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Observational Cohort Study is a multi-center study that collected self-reported symptoms, 3-day bladder diaries, physical examination, neuroimaging and sensory testing data, and biological
samples in over 1000 care-seeking men and women across six tertiary care centers. LURN is
focused on defining patient-reported outcomes in people with lower urinary tract dysfunction
(LUTD), conducting deep phenotyping of such individuals, and identifying biomarkers that
are associated with symptoms of LUTD [39,40]. In our previous study [41], we performed clustering of 545 women from the LURN Observational Cohort Study using baseline self-reported
urinary symptom data, captured with the LUTS Tool [42,43] and the American Urological
Association Symptom Index (AUA-SI) [44]. Four distinct clusters were identified. Women in
cluster F1 (n = 138) were continent, but reported post-void dribbling, frequency, and voiding
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symptoms. Cluster F2 (n = 80) reported urgency urinary incontinence, as well as urinary
urgency and frequency, and minimal voiding symptoms. Cluster F3 (n = 244) included
women reporting all types of urinary incontinence, urgency, frequency, and mild voiding
symptoms. Women in cluster F4 (n = 83) reported all LUTS at uniformly high levels. These
subtypes of LUTS were based solely on the above two questionnaires and require further
refinement, followed by clinical verification.
The current report describes the methodology and results of refining the female LUTS
symptom-based clusters by integrating multiple data domains collected in LURN: demographics, non-urinary symptoms, history, and physical examination data, as well as intake and voiding patterns captured in 3-day bladder diaries. We discuss preprocessing of heterogeneous
data and combination of continuous and categorical data using our novel weighted Tanimoto
indices approach. We use resampling-based consensus clustering [34] combined with a modified semi-supervised clustering approach [45,46] to make use of data available on only a subset
of participants. Then we determine the optimal number of clusters using our novel contrast
criterion (CC) developed for consensus clustering, and compare it with other consensus clustering criteria: proportion of ambiguous clustering (PAC) [47], and consensus score (CS) [35],
as well as with the established quality of clustering criteria, such as Calinski-Harabasz, DaviesBouldin, Dunn, and Silhouette [22–26]. We identify distinct clusters of women with LUTS
and show superiority of these clusters to our published symptom-based clusters [41], in terms
of the percentage of significantly different variables in pairwise comparisons of the clusters
and the confidence level in the determined cluster membership. Dynamics of the clusters in
12-month follow-up, as well as clinical relevance of the clusters, are discussed.
In the Methods section, we describe the analytical pipeline we developed and used for subtyping women with LUTS. We provide the rationale for our choices of methods for data preprocessing, integration, clustering, and cluster evaluation, as well as review of other available
options. We demonstrate that the developed pipeline allowed for identification of distinct and
robust refined clusters, with a higher percentage of significantly different variables across the
clusters than those previously published, and validate cluster distinctiveness by analyzing biomarker data. Finally, we review the methodological information needed to assess subtyping via
clustering and propose a set of reporting requirements that should ideally be included in all
clustering reports. We finish by calling for the clustering community effort to develop minimum requirements for clustering publications. We believe this paper would be of interest for
clinicians and researchers involved in subtyping of common complex diseases and disorders
using heterogeneous and multidomain data.

Materials and methods
LURN data used for subtyping of LUTS
Data on women with LUTS. Data for LUTS subtyping were obtained from the LURN
Observational Cohort Study [39,40], which included 545 women seeking care for LUTS at six
tertiary care centers. Baseline data collection included demographic information, medical history, physical examination findings, 3-day bladder diaries [48], and self-report questionnaires
of urologic and non-urologic symptoms. Urologic symptoms were collected using the LUTS
Tool [42–43] and the AUA-SI [44]. The LUTS Tool contains 44 items, including questions on
the frequency of occurrence and degree of bother for each urinary symptom. Possible answers
to the LUTS Tool questions were ranked from zero to four, zero indicating absence of the
symptom, and four indicating the most severe level of the symptom. The AUA-SI has eight
items, including a single overall bother question. Responses to the first seven questions of the
AUA-SI range from zero to five, zero indicating “none” or “not at all”, and five indicating
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“almost always”. The final question in the AUA-SI ranges from zero (delighted) to six (terrible). Participants also completed patient-reported outcome (PRO) questionnaires from the
Patient-Reported Outcomes Measurement Information System (PROMIS). We used questionnaires related to bowel function (PROMIS gastrointestinal constipation, diarrhea, and bowel
incontinence subsets) [49], psychological health (PROMIS Depression and Anxiety Short
Forms [50], Perceived Stress Scale [51], PROMIS Sleep Disturbance Short Form [52]), urologic
pain (Genitourinary Pain Index [GUPI]) [53], and pelvic floor function (Pelvic Floor Distress
Inventory [PFDI]) [54]. Demographics included: age, race, ethnicity, employment status, education level, and marital status. Physical examination data included: weight, waist circumference, BMI, post-void residual volume, pelvic organ prolapse (using the Pelvic Organ Prolapse
Quantification [POP-Q] system that measures the location of selected landmarks on the vagina
and cervix [55]), and presence of pathology findings at the introitus, urethra, vagina, uterus, or
rectum. Medical history data included Functional Comorbidity Index (FCI) [56], additional
individual comorbidities, as well as information on history of urinary tract infections (UTI),
pregnancy, vaginal deliveries, alcohol, smoking, recreational drug use, and medication use.
Individual comorbidities and medication use are categorial variables that were transferred into
binary variables, e.g., comorbidity A (present or absent, 1 or 0), medication B (used or not
used,1 or 0), and then clustered using the Tanimoto indices approach, described in the ‘Clustering Pipeline’ section below.
Bladder diaries included data on timing and volume of each beverage intake and urinary
void during a 72-hour period. Completeness and accuracy of bladder diaries collected in
LURN are described in [57]. Only 193 women (35%) returned bladder diaries deemed complete. For clustering purposes, we used the following five bladder diary variables from those
193 women: number of intakes and voids, total volumes of intakes and voids, and maximum
voided volume (serving as a proxy for bladder capacity).
In total, 185 variables were used for subtyping women with LUTS; 27 demographic variables, 55 medical history variables, 33 physical exam variables, 52 urinary symptoms variables
(LUTS Tool and AUA-SI), 13 non-urinary PRO variables, and 5 bladder diary variables. Variables were continuous (n = 83) or categorical (n = 102). S1 Table in S1 File presents an overview of these variables for 545 women with LUTS used in the analysis. Although all variables
were deemed important or possibly important in subtyping persons with LUTS, not all the variables are of equal importance, relevance, and non-redundancy; therefore, scaling and weighting of the variables was implemented as described below.
Data on non-LUTS controls. Our preprocessing procedure, described in more detail in
the next section, includes scaling of variables by standardizing their values using means and
standard deviations (SDs) in non-LUTS controls. The LURN study included 55 control
women, who were not necessarily healthy but did not report LUTS. Unfortunately, not all the
variables of interest were collected for these non-LUTS controls (e.g., physical examination,
bladder diary). As a source of bladder diary data for non-LUTS controls, we used bladder diaries of 32 non-LUTS controls from the Establishing Prevalence of Incontinence (EPI) community study of women in Southeastern Michigan [58]. For other variables of interest not
collected for non-LUTS controls, we used population data from literature sources indicated in
S1 Table in S1 File.

Biological samples collected and analyzed in LUTS cases and non-LUTS
controls
The LURN study collected numerous biological samples, including whole blood, serum,
plasma, and urine at baseline and at 3- and 12-month follow-up visits [39,40]. Of these
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samples, 230 baseline serum samples of women with LUTS and 30 serum samples of nonLUTS controls were analyzed using the targeted proteomics approach–Proximity Extended
Assay (PEA) by Olink Proteomics (Uppsala, Sweden). Three Olink panels (cardio metabolic,
inflammation, neurology) were used to quantify abundances of 276 proteins. These data were
not used for clustering in the current report; however, they served as an additional orthogonal
approach for evaluation of the quality of the identified clusters. We compared the abundances
of 276 proteins in women with LUTS and in controls and tested for significantly differentially
abundant proteins in each of the identified clusters versus controls adjusted for multiple comparison using the false discovery rate (FDR) correction (FDR<0.05) [59]. Note that assays
were performed in a subset (n = 230, 42%) of women.

Ethical guidelines and consent
The authors confirm all relevant ethical guidelines have been followed, and all research has
been conducted according to the principles expressed in the Declaration of Helsinki. Informed
written consent has been obtained from participants. Institutional Review Board (IRB)
approval has been obtained from: Ethical and Independent Review Services (E&I) IRB, an
Association for the Accreditation of Human Research Protection Programs (AAHRPP)
Accredited Board, Registration #IRB 00007807.

Overview of the clustering pipeline
The clustering pipeline implemented in this paper contains multiple steps of data preprocessing, integration, clustering, and cluster evaluation. In this subsection, we present an overview
of the sequence of steps in the pipeline shown in Fig 1. Details and rationale for each of the
steps are provided in the rest of the subsections of the “Materials and Methods” section below.
The pipeline is implemented using MATLAB (MathWorks, Natick, MA) and is publicly available through the Dryad repository (https://datadryad.org).

Data preprocessing
Multiple imputation. Due to missing data (up to 10% in self-report questionnaires of
urologic and non-urologic symptoms), multiple imputation was performed. The imputation
used a sequential regression technique and was implemented using IVEware version 2.0
[60,61]. Ten imputed data sets were constructed, and each was preprocessed as described
below. The k-means step of the resampling-based consensus clustering was performed on each
of the data sets separately, resulting in ten pairwise probabilities of being in the same cluster
for each pair of participants. Finally, hierarchical clustering on the mean of ten probabilities
(pairwise distances) was performed to determine cluster membership.
Scaling of continuous variables. Scaling variables prior to clustering is an important and
often overlooked step. Clustering algorithms group objects in a way that minimizes the sum of
the pairwise distances between participants within the cluster, where the distance is composed
of the distances between all variables calculated using Euclidian, Manhattan, or other suitable
metrics [9]. Since each variable is measured using its own scale, the distances and optimal partition of the objects depend on these scales. As stated in [62], the problem with unscaled,
unstandardized data is the inconsistency between cluster solutions when the scale of some of
the variables is changed, which is a strong argument in favor of standardization. It is especially
important in the case of heterogeneous data, where scales of variables in the raw data can be
very different and completely unrelated. A common form of conversion of variables to standard scores (or z-scores) entails subtracting the mean and dividing by the SD for each variable.
However, subtracting the cohort mean and dividing by the cohort SD would mask the subtype
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Fig 1. Flowchart of the pipeline for subtyping of a common complex disease or disorder by integrating heterogeneous data
as used for subtyping of LUTS. Three types of data are imputed. Continuous variables are scaled using controls, weighted,
normalized, and then clustered using consensus k-means clustering. Categorical data is transformed into binary and then
clustered using weighted Tanimoto indices approach. Matrices of pairwise distances for three types of data are then integrated to
maximize contrast criterion (CC) and proportion of core cluster members (PCC). Identified clusters are evaluated using several
clustering criteria and testing for significantly different variables in the pairwise comparison of the clusters.
https://doi.org/10.1371/journal.pone.0268547.g001
PLOS ONE | https://doi.org/10.1371/journal.pone.0268547 June 10, 2022
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differences, since it ignores whether the within-cohort variance is caused by the natural biological variability of the subjects or by differences in disease subtypes, which increase the withincohort variance due to multimodal distributions along certain variables. Using z-scores along
such variables will unduly reduce their weight and will mask the presence of the subtypes.
Therefore, standardization using z-scores is not suitable for our task of identifying disease subtypes. The solution to this problem is standardization by the mean and SD of a reference population that does not have the disease of interest, in this case, controls without LUTS. Following
this approach, we define standardized variables Sin [63]:
Sin ¼ ðAin

AiC Þ=siC

ð1Þ

where Ain–ith unstandardized variable for participant n, AiC-mean value of ith variable
across control subjects without disease of interest, σiC–SD of ith variable in control subjects
without disease of interest. A simulated example illustrating the benefits (substantially lower
misclassification error) of clustering using variables standardized according to equation (Eq
1), versus unstandardized variables and z-scores, is presented in Supplemental Material text in
S1 File.
Weighting variables to mitigate the redundancy. Clustering results can be skewed by
including variables reflecting redundant information. An obvious and extreme case example
will be including into the data set the same or highly correlated variables multiple times, which
will result in the dominating role of these variables in the overall sum of squared distances,
and therefore in the clustering decision. To mitigate this, we used weighting, so that the highest
weight was attributed to the least correlated variable (i.e., the variable with the smallest average
correlation with all other variables) and the lowest weight to the most correlated variable
[41,64]. The weights wi were defined by Eqs (2–4):
wi ¼

1
1 þ ci =cw

ð2Þ

m
X

ci ¼

rij =ðm

1Þ

ð3Þ

j¼1;j6¼i

m X
m
X

cw ¼

rij =mðm

1Þ

ð4Þ

i¼1 j¼1;j6¼i

where m -number of variables and rij Pearson correlation coefficients of variables i and j.
Row normalization for continuous variables. Initial attempts to cluster un-normalized
urinary symptoms data led to identification of two clusters that differed by overall severity of
LUTS, not subtypes of symptoms. To avoid clustering predominantly by the overall severity of
LUTS, in [41,64] and here, we normalized the data by the participant’s overall severity of disease. For each participant, the weighted Euclidean length of the vector composed of all 78 conqffiP
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
78
2
tinuous variables used for clustering was calculated as Ln ¼
i¼1 ðwi � Sin Þ , where Sin is the
scaled ith variable for the nth participant and wi is the weight of ith variable defined by Eqs (2–
4). Each continuous variable was then normalized by Ln, the Euclidean length of the participant’s vector, resulting in normalized continuous variables V in ¼ wi � SLinn . This normalization
strategy allowed for clustering based on the direction rather than the length of the vector representing each subject.
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Consensus clustering using continuous variables
Clustering was performed using a resampling-based consensus clustering method introduced
by Monti et al [34]. We performed 1000 instances of random resampling, each selecting a subset including 80% of participants. The same procedure was repeated for each of the ten multiply imputed data sets, resulting in 10,000 subsets. We then partitioned each of the subsets into
clusters using a k-means clustering algorithm implemented as k-means MATLAB function
(with option ‘number of replicates’ = 8, see [63] for the explanation on the need of this option);
with number of clusters K scanned from 2 to 12. Let Qnq denote the number of times participants n and q were assigned by k-means into the same cluster. Let Inq denote the number of
times participants n and q were both selected in the random sampling. The probability of participants n and q belonging to the same cluster could be calculated as Qnq/Inq. We could thus
obtain ten probabilities for a pair of participants from the ten imputed data sets. The average
of these probabilities represented the final consensus index Mnq for participants n and q. A 545
by 545 consensus matrix M (Fig 2) was constructed to visualize these average probabilities as a
heat map. Probability is color-coded: bright yellow represents probability close to one and
dark blue probability close to zero. The indices of participants were reordered so that the participants belonging to the same clusters were grouped together. To reorder the indices of participants in the consensus matrix, we employed hierarchical clustering (using clustergram
MATLAB function) with 1−M as distance matrix so that participants belonging to the same
clusters were grouped together, depicted as bright yellow blocks along the diagonal of consensus matrix.

Fig 2. Consensus matrix. Consensus (545x 545) matrix is presented as a heat map, where the probabilities Mnq for
each pair of participants to be in the same cluster are shown by color-coded elements; bright yellow represents
probability close to one and dark blue probability close to zero. Five yellow squares along the diagonal represent 5
clusters of participants with LUTS.
https://doi.org/10.1371/journal.pone.0268547.g002
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Clustering using categorical variables
Of 185 variables used for clustering women with LUTS, 102 (55%) are categorical. K-means is
not an appropriate method for categorical variables, so resampling-based consensus clustering
with multiple runs of k-means algorithm, which we used for continuous variables, cannot be
directly used for categorical variables.
k-prototype approach. One way to combine continuous and categorical variables is to use
the k-prototype algorithm introduced by Z. Huang [65]. According to [65], the distance
between two objects X, Y, described by p continuous variables and m-p binary variables, is represented as:
Pp
Pm
2
dðX; YÞ ¼ j¼1 ðxj yj Þ þ g j¼pþ1 dðxj ; yj Þ
ð5Þ
where δ is Kronnecker symbol describing simple matching and γ is the weight introduced in
[65] to “avoid favoring either type of attribute” (continuous vs. categorical). The goal of the kprototype algorithm is to minimize the sum of the distances (defined by Eq 5) between objects
within the cluster. Limitations of the k-prototype algorithm include lack of scaling of categorical variables and use of the same weight γ for all categorical variables, regardless of their relevance to the disease of interest or their redundancy. A later version of the algorithm [66]
attempted to overcome some of these limitations by defining the distance between an object
Xn and the centroid Zk of the kth cluster as:
Pp
Pm
2
dðZk ; Xn Þ ¼ j¼1 ðxnj Zkj Þ þ j¼pþ1 φðZkj ; xnj Þ
ð6Þ
8
< 1; if Zkj 6¼ xnj
�
� >
where φ Zkj ; xnj ¼
, and Ck is the number of objects in cluster k, while
Ckjr
>
; otherwise
:1
Ck
Ckjr is the number of objects in this cluster with the categorical value arj of the jth attribute, e.g.,
participants with blue eyes in cluster k. Such definition of distance makes sense; for instance, if
the number of participants in cluster k is 100, and 51 of them have blue eyes, then for a person
with brown eyes, distance from the centroid along this dimension is 1, but for a person with
blue eyes, it is 1–0.51 = 0.49. Now, if 99 participants have blue eyes, then for them, the distance
from the centroid is 1–0.99 = 0.01, while for the only one with brown eyes, it is still 1. Thus,
such a definition of distance makes certain attributes more important (defining) for the cluster
if the majority of objects have the same value of this attribute. An algorithm using such a definition of distance between objects would strive to make clusters as homogeneous as possible
with regard to both its continuous and categorical variables. This approach, however, does not
distinguish between categorical variables relevant and irrelevant to the disease of interest.
To distinguish between relevant and irrelevant variables, we suggest using the same
approach as for continuous variables, i.e., compare them with controls without the disease or
symptom complex of interest. For the categorical variables transformed into binary variables,
we suggest scaling by comparison of the frequencies of these binary variables in LUTS Fj and
in controls FjC by using the following function:
�
�
� � F ��
j �
�
gj ¼ �log
ð7Þ
�
FjC �
�
where |x| is absolute value of x.
If, for a certain binary variable, frequencies in LUTS and non-LUTS controls are equal, e.g.,
prevalence of blue eyes is the same in LUTS and non-LUTS, then this variable will get weight
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γj = 0 and would not affect clustering decision, essentially excluding the variable from clustering. However, if the frequency of this variable in LUTS is higher or lower than in controls,
then γj>0, and this, relevant to disease variable, will affect clustering decisions. To accommodate this scaling together with weighting of the variables based on their correlation with other
variables described by Eqs (2–4), one needs to modify Eq (6):
dðZk ; Xi Þ ¼

Pp
j¼1

wj ðxij

2

Zjk Þ þ

Pm
j¼pþ1

wj φðZkj ; xij Þgj

ð8Þ

Unfortunately, none of the available implementations of k-prototype algorithm in standard
software (R and SAS [67,68]) easily allows for such modification, and therefore, an alternative
simpler approach was used.
Weighted Tanimoto indices approach. A simpler approach to clustering categorical variables is based on Tanimoto indices or Tanimoto similarity measure [69]. For two objects a and
b described by m binary variables, Tanimoto similarity is defined as:
Pm
j¼1 aj � bj
T ¼ Pm 2
ð9Þ
2
aj � bj Þ
j¼1 ðaj þ bj
For instance, if a and b are 5-dimensional binary vectors a = [1, 1, 0, 0, 0] and b = [1, 0, 1, 0,
0], then T = 1/(2+2–1) = 1/3. Note that common “ones” but not common “zeros” are counted
in this definition of similarity, which is especially useful in case of multiple binary variables
formed from one categorical variable. Think, for example, of the categorical variable ‘eye color’
transformed into several binary variables: ‘blue eyes’ (yes, no), ‘brown eyes’ (yes, no), ‘green
eyes’ (yes, no), etc. Tanimoto similarity between two persons with blue eyes will not depend
on whether you add ‘hazel eyes’ to the list of options or not.
Not all of the categorical variables are equally relevant to the disease of interest, so we want
to be able to assign weights reflecting the level of relevance for each variable by comparing its
frequency in LUTS with its frequency in non-LUTS controls. We also want to compensate for
redundancy in the variables by using weights defined by Eqs (2–4). Importantly, we want to
make sure that no categorical variable, even if it is much more frequent in disease than in controls, has overwhelmingly high weight and makes the role of differences in other variables negligible. To attain this goal, we introduce a weighed Tanimoto similarity measure as:
Pm
T ¼ Pm
j¼1

j¼1

aj � bj � w2j � ðerfðgj ÞÞ

ðða2j þ b2j

2
2

aj � bj Þ � w2j � ðerfðgj ÞÞ Þ

;

ð10Þ

where wj is the weight defined by Eqs (2–4), using the appropriate correlation coefficients of
the variables. Coefficient γj is defined by Eq (7) and minimizes the role of binary variables
Rx
equally prevalent in disease and controls. Function erfðxÞ ¼ p2ffipffi 0 expð t2 Þdt ensures that the
weight of each binary variable is smaller or equal to one, even for the high values of γj, since |
erf(x)|�1. Note that maximum value of T is equal to one when all the categorical variables in a
and b are the same, and minimum value is zero when all the categorical variables are different.
Now we can use Eq (10) to define distance between any pair of participants described by J
binary variables as:
�

PJ

�

d Xn ; Xq ¼ 1

Tnq ¼ 1

PJ
j¼1
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j¼1

Xjn � Xjq � w2j � ðerfðgj ÞÞ

ððXjn2 þ Xjq2

2
2

Xjn � Xjq Þ � w2j � ðerfðgj ÞÞ Þ

ð11Þ

11 / 38

PLOS ONE

Subtyping complex disorders by clustering heterogeneous data

Combining continuous and categorical variables
Note the similarity of the pairwise distance 1−Tnq between two participants based on the categorical variables describing them (Eq 11), and pairwise distance 1−Mnq between these participants based on their continuous variables. The former is equal to zero when all the categorical
variables describing these two participants are the same, while the latter is equal to zero when
the two participants always were assigned to the same cluster by the 10,000 instances of kmeans in the resampling-based consensus clustering. Similarly, the former is equal to one
when all the categorical variables describing the two participants are different, while latter is
equal to one when these participants always were assigned to the different clusters in resampling-based consensus clustering. This similarity allows combining continuous and categorical
pairwise distances into a single distance measure Dnq, with a minimum value of zero and maximum value of one using the weighted Euclidean length approach:
qffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
2
2
Dnq ¼ ðð1 Mnq Þ þ m2 � ð1 Tnq Þ Þ=ð1 þ m2 Þ;
ð12Þ
where μ is the weight representing the relative role of the distances based on categorical variables and on continuous variables. We set it equal to the ratio of the number of non-redundant
P102
P78
categorical and continuous variables: m ¼ j¼1 wjcat = j¼1 wjcont , where wj are determined by
Eqs (2–4) using correlation coefficients appropriate to the distributions of the variables.

Semi-supervised clustering using bladder diary data
Of 545 women in the Observational Cohort of LURN, 193 (35%) returned complete bladder
diaries without missing volumes of voids and intakes. These data were deemed clinically
important to the subtyping of women with LUTS. One way to integrate data domains only
available on a subset is by using semi-supervised clustering methods [70,71]. If class membership for the members of the subset is known, then the objective function in the clustering of
the whole cohort should be modified as follows:
Pp PNk PNk
PNsk PNsk
2
WCSS ¼ j¼1 n¼1 q¼1 ðxnj xqj Þ þ n¼1 q¼1 hnq ;
ð13Þ
where WCSS—within cluster sum of squared distances, p–number of variables, n6¼q, Nk—
number of cohort participants in the given cluster k, Nsk—number of the participants in cluster k that were present in the subset. The values of hnq = −h are negative (reward, decreasing
the within-cluster-sum-of-squares [WCSS]) if participants n and m belong to the same cluster
according to subset classification, and is positive hnq = h (punishment, increasing WCSS) if
participants n and q belong to the different classes of the subset. This approach known as
“must-link, cannot-link” allows for using labels known from classification of the subset to
influence clustering of the cohort. The limitation of this approach, however, is that it does not
allow for different level of confidence in subset cluster membership, i.e., participants n and q
are either in the same subset cluster or not. In our case, additional data available for the subset
of participants do not provide 100% confidence in cluster membership for this subset; furthermore, the number of participants in the subset is lower than in the whole cohort, making the
subset clusters less robust. There is a measure of similarity, however, that is quantitative and
reflects the confidence in cluster membership; it is the pairwise distance between members of
the subset. We suggest using this measure to modify the pairwise distance defined by Eq 12 by
taking into account the similarity between members of the bladder diary (BD) subset:
Gnq ¼ max ððDnq þ r � ðBDnq
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where Dnq is defined by Eq 12, BDnq is the pairwise distance between members of the subset,
mBD is the mean pairwise distance between members of the subset, ρ is a parameter determined as described in the below sections. If either participant n or q, or both of them are not
members of the subset, their pairwise distance is not known and is assumed equal to the mean
pairwise distance within the subset mBD. For these participants, the second term of Eq 14 is
equal to zero; while, for members of the subset, it is either negative or positive depending on
whether BDnq is smaller or larger than mBD. Note that, since the second term might be negative, for some large values of ρ, the sum of the two terms is negative as well. However, the pairwise distance between the objects cannot be negative, and is therefore set to zero for these
cases.
We used five variables (number of intakes and voids, total volumes of intakes and voids,
and maximum voided volume) from the bladder diaries of the 193 participants to refine the
values of their pairwise distances. These five variables were scaled using bladder diary data for
controls [58] and then added to the 78 other continuous variables to calculate pairwise distances BDnq refined with bladder diary variables, as described in the subsection on consensus
clustering using continuous variables. Then it was introduced into Eq 14 to get the refined
matrix of the pairwise distances Gnq. The value of the coefficient ρ was determined by optimizing the quality of clusters, as defined in the following subsections.

Determining the number of clusters
Determining the number of clusters is an important step in any clustering process. In partitioning algorithms like k-means, it is necessary to decide on the number of clusters K prior to
running the algorithm. In agglomerative algorithms like hierarchical clustering, it is possible
to decide on the number of clusters when the dendrogram based on the distances between
objects is already created. It is common to try several values of K and then to compare the
resultant clusters by using various quality of clustering criteria, including Calinski-Harabasz,
Davies-Bouldin, Dunn, Gap, and Silhouette indices [22–26]. Quite often, these criteria disagree on the value of K that optimizes the quality of the clusters.
Resampling-based consensus clustering, introduced in [34] and subsequently applied to
our data set, is a combination of multiple instances of k-means clustering followed by hierarchical clustering on the pairwise distances between objects derived at the first stage. The value
of K in k-means is typically scanned (in our case from 2 to 12), and then the optimal value of K
is determined using criteria developed specifically for consensus clustering algorithm
[34,35,47]. In both [34] and [47], the determination of the number of clusters is based on analysis of the cumulative distribution function (CDF) of consensus index values Mnq (defined in
the “Consensus clustering using continuous variables” subsection of this paper). The main
idea of this analysis is that, in case of ideal clustering, there are only two possible values of consensus index Mnq = 1, when a pair of objects n and q are in the same cluster, and Mnq = 0,
when they are in the different clusters. Therefore, the ideal CDF should consist of two vertical
lines and a horizontal (flat) line between them. The length of the first vertical line will be equal
to the number of pairs with Mnq = 0 and the length of the second vertical line to the number of
pairs with Mnq = 1. However, if the value of K used in clustering is different from the true
value of K, then the shape of the CDF curve differs from the idealized curve described above.
In [34], the optimal K is defined as the one for which the change in the area under the CDF
(relative to area at K-1 and K+1) is the largest (“elbow” of the AUC vs. K curve). Analysis in
[47] demonstrates several examples when the criterion of [34] does not work and suggests an
alternative criterion named proportion of ambiguously clustered pairs (PAC) equal to the
number of pairs with 0<Mnq<1 over the total number of pairs. Obviously, in the real-world
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situation of biological variability and noisy measurements, almost all of the pairs will fall into
this category, so some more liberal lower and upper boundaries for Mnq need to be introduced,
e.g., 0.1 and 0.9, as in [47]. It raises a question, however, whether these boundaries should be
different for different values of K, since potential ambiguity increases with the increased number of clusters.
A more straightforward approach to determine the number of clusters is used in [35] by
introducing mean consensus score (CS) calculated as the mean value of consensus indices Mnq
within the clusters. The value of K that results in the highest CS is considered optimal. The
problem with CS is that it favors the high number of clusters, e.g., CS could reach its maximum
when K = N/2 and each cluster contains only a pair of most similar objects with highest values
of Mnq.
Below, we introduce a pair of complementary criteria, i.e., contrast criterion (CC) and proportion of the core clusters (PCCs), which we used in our clustering pipeline. We believe they
combine the advantages of PAC and CS and are free of some of their limitations, especially
when used as a complementary pair. The below sections introduce the CC and PCCs based on
the analysis of consensus matrix derived by k-means clustering of the multiple resampling
instances of the data set; however, these criteria can be used with any matrix of pairwise distances between the objects.
Contrast criterion. The idea of the CC is derived from visual representation of the consensus matrix as a heat map presented in Fig 2. Each pixel of the heat map represents the value
of Mnq probability of two objects to be together in the same cluster. Each bright yellow square
along the diagonal of the matrix represents a cluster. Next, we compared the “bright yellowness” of this diagonal square with the “color” of the rest of the row in which the diagonal
square is located; therefore, the term “contrast criterion” (CC). The larger the difference
between these two measures, the further the situation from the case where all Mnq except for
n = q are equal, and the heat map is uniformly yellowish (single uniform cluster case), in
which case the contrast is zero. We consider number of clusters K and cluster membership
optimal when CC is maximized.
When analyzing the properties and behavior of clustering criteria, it is necessary to compare the clusters identified using certain clustering algorithms and clustering criteria of interest with the “true” clusters. Unfortunately, “true” clusters are not known in real life, and
therefore, one needs to simulate them and then evaluate misclassification error resulting from
the clustering algorithm and criteria of interest. Such an approach was used in [63] to compare
several popular clustering algorithms, and was applied for the case of resampling-based consensus clustering with CC and PAC criteria (see Supplemental Material text and S2-S10 Figs in
S1 File). Here, we concentrate on the general analysis of CC and its properties. In this analysis,
we need to introduce the term “alleged clusters”, which are different from “true clusters” and
“identified clusters”. “Alleged clusters” are determined for each value of K tried by clustering
algorithm, while “identified clusters” are those maximizing the value of clustering criteria of
interest, and “true clusters” are specified by the simulation.
To define CC explicitly, let us first look at the most typical case where the number of alleged
clusters is not equal to the number of objects, is not equal to one, and none of the clusters
includes just one object. Note that we are not making any assumptions or imposing any
restrictions on the properties of the “true” clusters.
For K 6¼ N; K 6¼ 1; Nj 6¼ 1; CC ¼

PK
k¼1

(PN PN
k
k
n¼1

q¼1;q6¼n

Nk ðNk

Mnq

1Þ

PK

PNk PNi

i¼1;i6¼k

n¼1

Nk ðN

q¼1

Nk Þ

Mnq

)
=K; ð15Þ

where K is the number of alleged clusters, N is the number of the clustered objects, Nk and Ni
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are the numbers of objects in kth and ith clusters. As intended, the first term in the brackets of
Eq (15) represents the average “bright yellowness” of the diagonal square, while the second
term in the brackets represents the average “yellowness” of the rest of the row in which the
diagonal square is located.
Note that we defined CC as an averaged contrast across alleged K clusters independently of
the size of the clusters. Other approaches are possible, e.g., a weighted average based on the
sizes of the clusters, or minimax approach, where the contrast for the “worst” (least contrast
cluster) is maximized. Clearly, the best choice of combining contrasts of each of the clusters
into one overall depends on many factors, including the goal of the clustering, expected sizes
of the clusters, and the number and distribution of the variables. It is an interesting topic; however, it is outside of the scope of this paper.
Another choice made in defining CC by Eq (15) is omitting of the diagonal terms Mnn,
which are always equal to one. The percentage of diagonal terms in each square representing
an identified cluster is NNk2 ¼ Nk 1 , or 100%, 50%, 33%, 25% for Nk = 1, 2, 3, 4. Since Mnn = 1,
k

Mnq<1, inclusion of diagonal terms in the definition of CC would favor smaller clusters over
larger clusters by assigning higher CC to the smaller clusters, irrespective of similarities of
objects within the clusters. Therefore, we do not include diagonal terms in the definition of
CC, as shown in Eq 15. Note that Eq (15) does not work if K = 1, K = N, or Nj = 1. For these
special cases, CC is defined and discussed in Supplemental Material text in S1 File.
There are certain similarities between our contrast criterion CC and consensus score (CS)
of [35]. Although the exact definition of CS is not provided, it appears that CS is similar to the
first term of Eq (15). However, it is unclear if the diagonal terms Mnn are omitted or included
and how CS for K clusters are combined to derive the overall CS. Nevertheless, it is of interest
to compare the behavior of CS and CC in some simple idealized cases. In case of ideal clustering, both CS and CC reach their maximum possible value of 1. The worst-case scenario for
both criteria is the case where K>1 clusters are alleged, when in reality, there are no “true”
clusters, and all objects are described by a unimodal random distribution of their attributes
(variables). Now, if the number of alleged clusters K >1, there is an equal probability for the
object to end up in any of K clusters, so the mean value of Mnq is 1/K, which makes the minimal possible value for CC equal to zero and minimal possible value for CS equal to 1/K. The
rather limited range of values from 1/K to 1, together with the dependence of the minimal
value on the number of alleged clusters, are the limitations of the CS criterion, which are
absent in case of CC, where the range is from 0 to 1 irrespectively of K. Therefore, we consider
the use of CC advantageous for determining the optimal number of clusters.
Core clusters. When analyzing the quality of alleged clusters, it is important to know the
confidence with which cluster membership is determined. Clearly, one would prefer clusters
where the probability of objects to belong to a particular cluster is 0.9 rather than 0.3. The
knowledge of consensus matrix allows for calculating the probability for each object n belonging to a particular cluster k:
PNk
q¼1q6¼n Mnq
pnk ¼
ð16Þ
Nk 1
Note that it is different from the probability averaged across the cluster that was used to calculate CS and CC in the previous subsection. Importantly, within the same cluster, some
objects might have probability (confidence) as high as πnk = 0.9999. . ., or as low as πnk = 1/K
+0.001, assuming that it is lower for any other cluster i6¼k. We will call the nth object the core
member of cluster k if πnk>0.5, which means that, for this object, the probability to be in cluster k is higher than probability to be in all other clusters combined. The rest of the members of
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Fig 3. Determination of the optimal number of refined clusters. (A) Consensus matrix heat map demonstrates five clusters of participants (named W1-W5)
grouped together based on the pairwise distances Gnq (Eq 14). (B) Contrast criterion (CC Eq 15) for K = 2,. . .,12. (C) Proportion of core cluster members (PCC
Eq 16) for K = 2,. . .12. Both CC and PCC have maxima at K = 5, justifying the selection of five clusters.
https://doi.org/10.1371/journal.pone.0268547.g003

the cluster do not belong to the core; for them, the probability to belong to the kth cluster is
just higher than to be in any other given cluster. The number of core members divided by the
total number of objects in the cluster provides a useful measure that we named proportion of
the core cluster (PCC). As with the contrast criterion CC, one can use several approaches to
derive overall PCC from the PCCs for each cluster, i.e., take the average across all clusters,
weighted average based on the size of the clusters, or minimax by looking at the PCC in the
worst cluster. PCC provides a measure of overall confidence in the alleged cluster membership
and of the uniformity of the alleged clusters. Unlike contrast CC, PCC favors smaller size of
the clusters and reaches its maximum when K = N/2 and each cluster contains just a pair of
objects. PCC reveals information similar to the proportion of ambiguously clustered pairs
(PAC) [47], for which 0.1<Mnq<0.9; however, PCC is easier to interpret and does not include
unjustified upper and lower boundaries 0.1 and 0.9.
Using CC and PCC to determine optimal number of clusters K. We used a combination
of CC and PCC to determine the optimal number of clusters K. Note that Eq 14 contains undefined coefficient ρ. Therefore, we have two parameters ρ and K to determine and two criteria
to meet. We determined ρ and K as the values maximizing CC and corresponding to an elbow
(point of diminishing returns) for PCC. A clustering procedure was run for 24 values of ρ
from 0.05 to 1.2 using the single-program multiple data sets (spmd) function of MATLAB Parallel Computing Toolbox; K values were scanned from K = 2 to K = 12. The determined optimal values were ρ = 0.3 and K = 5. The resultant consensus matrix together with the values of
CC and PCC for K scanned from 2 to 12 are presented in Fig 3. As seen in Fig 3, contrast criterion CC and percent of core cluster members PCC both have maxima for number of clusters
K = 5. As shown in Table 1, other quality of clustering criteria also confirm K = 5 as an optimal
number of clusters for our cohort of women with LUTS.

Table 1. Other quality of clustering criteria, confirming K = 5 as an optimal number of clusters.

Calinski-Harabasz (")

K=2

K=3

K=4

K=5

K=6

K=7

K=8

K=9

K = 10

1382.26

346.13

676.29

1126.25

567.83

398.02

309.93

234.52

180.57

Davies-Bouldin (#)

0.4328

0.8175

0.6045

0.4720

0.5692

0.9178

1.0809

1.1498

1.1678

Dunn (")

0.0167

0.0072

0.0290

0.0485

0.0496

0.0455

0.0273

0.0754

0.0590

Point-Biserial (#)

-4.801

-2.728

-3.25

-3.849

-2.515

-2.081

-1.855

-1.621

-1.409

Silhouette (")

0.6896

0.4565

0.5731

0.6857

0.5955

0.4821

0.3723

0.3143

NaN

https://doi.org/10.1371/journal.pone.0268547.t001
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Evaluation of the quality of the identified clusters
We used multistep procedure to evaluate the quality of identified clusters and compare with
the potential alternative clusters. The first step was examination of CC and PCC for each of K
clusters (Fig 3). Next, we calculated other established quality of clustering criteria, including
Calinski, Davies-Bouldin, Dunn, Point-Biserial, Silhouette [22–26], etc. (Table 1). Then, we
performed pairwise comparison of the clusters using Wilcoxon rank sum tests and chi square
tests, where appropriate, to determine which variables used for clustering were significantly
different in the pairwise comparison. All pairwise comparisons were adjusted using an FDR
correction for multi-testing [59].

Visualization of the results
We used several tools to visualize the results of our analyses. Heat maps representing the consensus matrices were generated using the clustergram MATLAB function. Properties of the
identified clusters were illustrated by radar plots, built-in using SAS statistical graphics panel
(sgpanel) scatter, polygon, and vector procedures. Comparison of cluster membership in the
refined clusters versus previously identified symptom-based clusters was performed using Sankey diagrams, built with the googleVis package.

Results and discussion
Description of the clusters
Five distinct clusters of women with LUTS were identified by clustering 545 participants of the
LURN Observational Cohort Study using 185 variables. We call these clusters W1-W5, in
order to distinguish them from clusters F1-F4, described previously [41]. Demographic data
for each cluster are presented in Table 2. Some demographic characteristics were different
across the clusters, including age, ethnicity, menopausal status, obesity, prevalence of hysterectomy, percentage of participants with at least one vaginal birth, education level, and employment status. No significant differences across the clusters were observed for race, smoking,
and alcohol use.
Importantly, all urinary symptoms and many other clinical variables were significantly different across the clusters. Table 3 presents the comparison of urinary symptoms (collected
with LUTS Tool and AUA-SI), bladder diary variables, and other 37 significantly different
clinical variables across clusters W1-W5. For clarity, we describe these significantly different
variables while discussing signatures of the clusters in the text following Table 3. Table 2, and
especially Table 3, illustrate the distinctiveness of the identified five clusters of women with
LUTS.
Properties of the five clusters are visualized in Fig 4. Each column represents one of five
clusters. Radar plots in the first row illustrate urinary symptoms measured by LUTS Tool and
AUA-SI; the second row illustrates demographics, clinical measurements, and non-urinary
PROs; the third row shows categorical data on comorbidities and anomalies identified during
the physical exam; the fourth row shows intake and voiding pattern variables collected in bladder diaries. Radar plots represent mean values of the raw variables across members of each of
the clusters. None of the clusters could be characterized by a single symptom, but rather by a
combination of symptoms with various levels of severity. Women in all five clusters reported
higher than normal frequency of voiding (with the highest frequency in W3 and W5). Women
in all clusters except W1 reported urinary urgency and some level of incontinence.
Women in cluster W1 (n = 77) reported minimal urinary incontinence, but had mostly
voiding and post-micturition symptoms (post-void dribbling, trickling, straining, hesitancy,
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Table 2. Demographic data for clusters W1-W5.
W1
N
Age (median IQR)

W2

W3

W4

W5

77

64

144

95

165

53 (36–60)

66 (51–71)

60 (50–70)

51 (42–63)

59 (51–67)

Race

P-Value
<0.0001
0.221

White

66 (86%)

60 (94%)

116 (81%)

80 (84%)

130 (79%)

Black

8 (10%)

2 (3%)

22 (15%)

8 (8%)

26 (16%)

Asian

3 (4%)

2 (3%)

3 (2%)

5 (5%)

3 (2%)

Other

1 (1%)

2 (3%)

3 (2%)

3 (3%)

6 (4%)

74 (96%)

57 (89%)

138 (96%)

84 (88%)

159 (96%)

Hispanic or Latino

1 (1%)

5 (8%)

3 (2%)

10 (11%)

2 (1%)

Unknown

2 (3%)

2 (3%)

3 (2%)

1 (1%)

4 (2%)

Obese

23 (30%)

15 (23%)

72 (50%)

38 (40%)

99 (60%)

<0.0001

Post-menopausal

35 (46%)

46 (73%)

102 (71%)

47 (49%)

117 (72%)

<0.0001

Had a hysterectomy

17 (22%)

9 (14%)

49 (34%)

25 (26%)

64 (39%)

0.0013

At least one vaginal birth

35 (45%)

60 (94%)

91 (63%)

75 (79%)

128 (78%)

<0.0001

Never

10 (13%)

5(7%)

20 (14%)

15 (17%)

40 (25%)

0–3 drinks per week

55 (72%)

46 (73%)

89 (62%)

65 (68%)

100 (61%)

4–7 drinks per week

8 (11%)

9 (14%)

21 (15%)

13 (14%)

15 (9%)

More than 7 drinks per week

0 (0%)

3 (4%)

8 (6%)

2 (2%)

5 (3%)

Never smoker

50 (67%)

43 (68%)

99 (69%)

64 (67%)

92 (56%)

Former smoker

21 (28%)

19 (30%)

33 (23%)

28 (29%)

52 (32%)

Current smoker

3 (4%)

1 (2%)

10 (7%)

3 (3%)

18 (11%)

Ethnicity

0.016
Non-Hispanic/Latino

Alcoholic drinks per week

0.0706

Smoking status

0.1746

Education

0.0058

Less than Associate degree

40 (30%)

24 (30%)

89 (30%)

27 (28%)

76 (47%)

Associates or Bachelor’s degree

32 (43%)

25 (40%)

58 (41%)

45 (47%)

61 (38%)

Graduate degree

23 (31%)

19 (30%)

41 (29%)

23 (24%)

24 (15%)

Full-time

35 (47%)

27 (42%)

50 (35%)

44 (46%)

51 (31%)

Part-time

13 (17%)

5 (8%)

20 (14%)

17 (18%)

21 (13%)

Unemployed (looking or not looking for work)

27 (36%)

32 (50%)

73 (51%)

34 (36%)

90 (56%)

Employment

0.0350

https://doi.org/10.1371/journal.pone.0268547.t002

and incomplete bladder emptying). They were younger than the average across the LURN
female cohort, had a lower than average weight, number of pregnancies, and vaginal births.
They had less comorbidities and abnormal findings in the physical exam. Women in cluster
W2 (n = 64) reported mild urinary symptoms, including mild urinary incontinence. They presented clinically significant anterior vaginal wall prolapse (mean POP-Q point B anterior [Ba]
= 1.24 cm, which is outside the introitus), apical prolapse (mean POP-Q point C = -2.38 cm),
and the most severe pelvic organ prolapse symptoms (with the highest Pelvic Organ Prolapse
Distress Inventory [POPDI-6] values of 20.60). They were on average older (66 vs. 53 years
old), and had a higher number of pregnancies (2.9 vs. 1.8) and vaginal births (1.47 vs. 0.92)
than women in cluster W1. They also had the highest post-void residual urine volume (75 mL)
across the clusters. Women in cluster W3 (n = 144) reported high urinary frequency, urinary
urgency, and urgency urinary incontinence. They had increased weight, had larger waist circumference, and higher functional comorbidity index (FCI) than women in W1, W2, and W4.
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Table 3. Urinary symptoms, bladder diary variables, non-urinary symptoms, and clinical variables across clusters W1-W5.
Cluster W1

Cluster W2

Cluster W3

Cluster W4

Cluster W5

77

64

144

95

165

Frequency

1.92

1.72

2.65

1.67

2.70

<0.001

Daytime frequency

1.67

1.44

2.09

1.37

2.13

<0.001

N

P-Value

Nocturia

1.85

1.16

1.89

1.22

2.06

<0.001

Incomplete emptying

1.76

1.16

1.20

0.86

2.37

<0.001

Trickle/dribble

1.69

1.07

1.28

1.11

2.56

<0.001

Urgency

1.10

1.47

2.88

1.76

2.73

<0.001

Hesitancy

1.18

0.72

0.34

0.27

1.26

<0.001

Intermittency

1.12

0.73

0.32

0.28

1.28

<0.001

Straining

1.04

0.49

0.16

0.11

1.09

<0.001

Weak stream

0.84

0.79

0.43

0.22

1.52

<0.001

Spraying

0.87

0.60

0.46

0.45

1.55

<0.001

Urgency with fear of leakage

0.56

1.34

2.85

2.05

2.69

<0.001

Bladder pain

0.94

0.50

0.34

0.34

1.42

<0.001

Burning with urination

0.44

0.24

0.10

0.12

0.72

<0.001

Urinary incontinence (UI)

0.59

1.24

2.39

2.81

2.96

<0.001

Post-void UI

0.74

0.65

0.71

1.44

2.31

<0.001

Urgency UI

0.37

1.06

2.61

2.00

2.71

<0.001

Stress UI (laughter)

0.55

1.03

1.26

2.86

2.57

<0.001

Stress UI (exercise)

0.46

0.78

0.90

2.94

2.35

<0.001

UI with sleep

0.10

0.35

0.73

0.88

1.64

<0.001

UI with sex

0.16

0.33

0.12

0.75

0.80

<0.001

UI no reason

0.21

0.56

0.89

1.66

2.13

<0.001

Nocturia (AUA-SI)

2.37

1.77

2.18

1.57

2.37

<0.001

Frequency (AUA-SI)

3.15

2.25

2.96

2.26

3.13

<0.001

Intermittency (AUA-SI)

1.74

1.12

0.53

0.41

1.95

<0.001

Weak stream (AUA-SI)

1.25

1.12

0.60

0.36

2.09

<0.001

Straining (AUA-SI)

1.44

0.57

0.12

0.16

1.08

<0.001

Incomplete emptying (AUA-SI)

2.18

1.28

1.04

0.79

2.67

<0.001

Urgency (AUA-SI)

1.59

2.17

3.63

2.18

3.53

<0.001

QOL (AUA-SI)

3.68

3.57

4.46

4.66

4.88

<0.001

Weight (Kg)

75.58

75.47

82.62

80.58

87.64

<0.001

Waist circumference (Cm)

94.74

97.13

100.59

95.58

106.35

<0.001

Systolic blood pressure

122.42

131.00

130.92

124.29

130.17

<0.001

Post-void residual volume (mL)

55.43

75.04

41.29

29.09

39.94

0.012

POP-Q: Ba result

-2.65

1.24

-2.23

-1.78

-1.86

<0.001

POP-Q C result

-6.85

-2.38

-6.52

-6.54

-5.85

<0.001

POP-Q D result

-7.96

-4.43

-7.79

-7.42

-6.79

<0.001

Number of pregnancies

1.80

2.90

2.01

2.48

3.07

<0.001

Number of vaginal births

0.92

2.43

1.47

1.72

2.02

<0.001

Functional Comorbidity Index Total

1.66

1.74

2.48

1.24

3.64

<0.001

GUPI pain

5.09

4.15

3.70

2.23

6.84

<0.001

GUPI urine

4.71

3.40

3.67

2.49

5.67

<0.001

GUPI QOL

5.78

5.68

6.85

7.60

8.70

<0.001

POPDI-6

14.50

20.60

7.57

7.25

30.22

<0.001

Colorectal-anal distress inventory (CRADI-8)

12.98

18.03

14.76

10.99

33.50

<0.001

Urinary distress inventory (UDI-6)

24.42

25.44

36.27

39.58

63.67

<0.001
(Continued )
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Table 3. (Continued)
Cluster W1

Cluster W2

Cluster W3

Cluster W4

Cluster W5

Perceived stress scale

12.09

9.29

11.89

11.29

16.44

P-Value

PROMIS constipation T-score

50.30

48.68

49.00

49.89

55.80

<0.001

PROMIS depression T-score

48.91

44.63

48.67

46.61

53.93

<0.001

<0.001

PROMIS anxiety T-score

49.84

46.78

48.61

48.11

54.75

<0.001

PROMIS sleep disturbance T-score

53.48

49.08

52.17

51.52

56.83

<0.001

PROMIS diarrhea T-score

45.70

46.37

48.43

45.17

53.98

<0.001

PROMIS physical functioning T-score

50.44

49.85

46.84

53.19

42.24

<0.001

Arthritis diagnosis

23 (30%)

29 (46%)

64 (45%)

20 (21%)

94 (58%)

<0.001

Asthma diagnosis

12 (16%)

7 (11%)

29 (20%)

7 (7%)

49 (30%)

<0.001

Chronic obstructive pulmonary disease (COPD) diagnosis

1 (1%)

5 (8%)

6 (4%)

1 (1%)

19 (12%)

0.001

Diabetes diagnosis

4 (5%)

8 (13%)

22 (15%)

5 (5%)

36 (22%)

0.004

Upper gastrointestinal disease diagnosis

19 (25%)

15 (24%)

34 (24%)

12 (13%)

71 (44%)

<0.001

Depression diagnosis

17 (22%)

9 (14%)

53 (37%)

27 (28%)

79 (49%)

<0.001

Anxiety or panic disorder diagnosis

13 (17%)

8 (13%)

35 (24%)

20 (21%)

62 (38%)

<0.001

Degenerative disc disease diagnosis

10 (13%)

7 (11%)

29 (20%)

10 (11%)

57 (35%)

<0.001

History of pelvic pain

15 (20%)

3 (5%)

7 (5%)

11 (12%)

37 (23%)

<0.001

Sexual activity with the last month

41 (54%)

27 (43%)

54 (38%)

58 (61%)

56 (34%)

<0.001

History of hypertension

20 (26%)

21 (33%)

61 (43%)

23 (24%)

80 (49%)

<0.001

History of hyperlipidemia

14 (18%)

24 (38%)

44 (31%)

22 (23%)

67 (41%)

0.009

History of sleep apnea

9 (12%)

10 (16%)

21 (15%)

9 (9%)

45 (28%)

0.005

History of a psychiatric diagnosis

32 (42%)

11 (17%)

55 (38%)

41 (43%)

93 (57%)

<0.001

Past surgical procedure for LUTS

4 (5%)

6 (10%)

23 (16%)

11 (12%)

36 (22%)

0.008
0.004

No abnormal vaginal findings on physical exam

57 (75%)

35 (56%)

101 (72%)

78 (82%)

124 (77%)

No abnormal uterus findings on physical exam

50 (68%)

45 (71%)

83 (60%)

69 (73%)

87 (54%)

0.009

No notation of tenderness on physical exam

44 (59%)

50 (79%)

108 (77%)

84 (88%)

131 (81%)

<0.001

Average number of voids in 24 hours

7.6

7.5

8.4

7.1

8.6

0.0023

1827.0

1717.5

1786.6

1786.6

1813.5

0.6728

Average number of intakes in 24 hours

6.5

6.4

6.3

6.3

6.4

0.7081

Average volume of intakes in 24 hours

1902.8

1682.9

1813.3

1813.3

1810.1

0.3028

Max voided volume

531.9

543.2

473.4

473.4

519.0

0.2134

Average voided volume in 24 hours (mL)

https://doi.org/10.1371/journal.pone.0268547.t003

They most frequently reported “urgency with fear of leakage” (2.85), but did not report any
substantial post-voiding symptoms. Women in cluster W4 (n = 95) reported multiple symptoms associated with stress urinary incontinence, as well as urgency urinary incontinence, and
some post-void urinary incontinence. They were younger (mean 51 years), had less medical
comorbidities (FCI = 1.24), and had a higher level of physical functioning (PROMIS Tscore = 53.2) than others in the cohort. Women in W5 (n = 165) reported higher frequencies
and severities of LUTS for all symptoms. For 27 out of 30 urinary symptoms, they reported the
highest levels across all five clusters. These women were heavier (87.6 Kg), had the lowest level
of physical functioning (PROMIS T-score = 42.2), had more medical comorbidities
(FCI = 3.64), and more pregnancies (3.07) than the rest of the cohort. They also reported
higher psychosocial difficulties in depression, anxiety, and perceived stress, as well as sleep disturbance. Clusters W2 and W4 had higher percent of Hispanic or Latino women than three
other clusters.
The presence of multiple significantly different variables across the clusters demonstrates
that clusters W1-W5 meet the concise definition of clustering given by Liao as: “The goal of
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Fig 4. Radar plots illustrating mean values of urinary symptoms, demographics, clinical measurements, non-urinary PROs, comorbidities, and bladder
diary variables for identified five clusters of women with LUTS. First row–urinary symptoms (LUTS Tool). Second row–clinical, non-urologic PRO, and
demographic variables. Third row–comorbidities and anomalies identified by physical examination. Fourth row- bladder diary variables. Urinary symptoms
are color-coded: Green = frequency; blue = post-micturition; purple = urgency; dark blue = voiding; red = pain; orange = incontinence.
https://doi.org/10.1371/journal.pone.0268547.g004

clustering is to identify structure in an unlabeled data set by objectively organizing data into
homogeneous groups where the within-group-object dissimilarity is minimized and the
between-group-object dissimilarity is maximized” [8]. Fig 5 visually illustrates results of pairwise comparisons of the clusters in a matrix form. Fig 5A provides cluster comparisons by
LUTS Tool variables. Elements on the diagonal of the matrix present the level of severity for
each LUTS Tool question, i.e., the severity urinary symptom signature of the cluster. The triangle of boxes above the diagonal demonstrates variables significantly different in the pairwise
comparison of the clusters; each colored bar indicates a significantly different variable. As
seen, the majority of symptoms are significantly different in the pairwise comparison of the
clusters. Elements in the lower triangle of the matrix present the difference in symptom severity levels; e.g., the first (upper) element in the triangle represents the difference between symptom severity levels in cluster W2 and cluster W1, indicating that urgency symptoms are more
severe in cluster W2, while voiding and pain symptoms are more severe in cluster W1 than in
cluster W2. Similarly, Fig 5B and 5C provide the results of pairwise comparison of the clusters
for other variables from Tables 2 and 3, demonstrating multiple significantly different non-
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Fig 5. Results of the pairwise comparison of clusters W1-W5. (A) LUTS Tool variables. (B) Demographic and
clinical variables. (C) Physical examination and comorbidities data. Boxes above the diagonal demonstrate significantly
different variables in the pairwise comparison of the clusters. Each colored bar represents a significantly different
variable. Boxes on diagonal are similar to radar plots and demonstrate the “signatures” of the clusters. Boxes below
diagonal present the difference in the values of variables for each pair of clusters. Clusters are distinct and significantly
different, not only by their urinary symptom signatures, but by multiple non-urologic variables, and comorbidities as
well.
https://doi.org/10.1371/journal.pone.0268547.g005

urologic symptoms, physical examination, clinical and demographic variables. In summary, clusters are distinct and significantly different, not only by their urinary symptom signatures, but by
multiple non-urologic variables as well. Importantly, these significant differences are demonstrated by omnibus test (Tables 2 and 3) and by pairwise comparison of the clusters (Fig 5).

Differential protein abundance in serum of women with LUTS versus nonLUTS controls
Fig 6 presents the volcano plots comparing abundances of 276 proteins in baseline serum samples of women with LUTS versus non-LUTS controls. Fig 6A compares the abundances for all
230 women with LUTS to 30 controls, while Fig 6B–6F provide similar comparisons for members of the identified clusters W1-W5 for whom proteomics data was available (n1 = 37,
n2 = 38, n3 = 53, n4 = 42, n5 = 60). S3 Table in S1 File provides the lists of significantly

Fig 6. Volcano plots demonstrating differentially abundant proteins in women with LUTS vs. controls for 230 participants representing. (A) the whole
cohort; and (B-F) for each of identified clusters W1-W5. Volcano plots allow for identification and visual representation of the differences in the data sets. Each
small circle on volcano plots (A-F) represents mean abundance of one of 276 proteins in women with LUTS compared to non-LUTS controls. Horizontal axis
represents mean fold-change on the logarithmic scale, while vertical axis represents p-value on the logarithmic scale. The higher the circle, the more
significantly different its abundances in LUTS versus controls. The further the circle from zero on the horizontal axis, the larger the fold-change.
https://doi.org/10.1371/journal.pone.0268547.g006
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Table 4. Proportion of significantly different variables in clusters W1-W5 and F1-F4.
W1
W1

W2

W3

W4

W5

27%

46%

58%

64%

F1

39%

37%

83%

F2

34%

34%

66%

F3

47%

27%

69%

F4

58%

51%

52.3%

Mean

W2

27%

W3

47%

27%

W4

58%

37%

34%

W5

64%

83%

66%

F1

F2

F3

F4

34%

47%

58%

27%

51%
39%

39%

69%

Mean

42.7%

https://doi.org/10.1371/journal.pone.0268547.t004

differentially abundant proteins for each of the comparisons. Multiple differentially abundant
proteins are observed in the serum samples of women with LUTS versus non-LUTS controls,
both overall and between each cluster and controls. While some of these have been shown [72]
to be associated with LUTS (e.g., tumor necrosis factor [TNF], interleukin-10 [IL-10], monocyte chemotactic protein [MCP], and transforming growth factor [TGF]), the remainders are
novel. The highest number of the differentially abundant proteins of 70 (29 after FDR correction for multiple testing) is observed for cluster W5, which demonstrated the highest level of
all urinary symptoms and comorbidities. Note that overlap between the lists of differentially
abundant proteins is quite low, meaning that clusters W1-W5 are “biochemically” different.
The highest overlap of 18 differentially abundant proteins is observed for cluster W5 and cluster W3, defined mainly by high urinary frequency, urinary urgency, and urge urinary incontinence. Interestingly, the lowest number of differentially abundant proteins (n = 10) are
observed in clusters W2 (characterized by the presence of pelvic organ prolapse) and W4
(characterized by the presence of stress urinary incontinence), which are presumably driven
by anatomic abnormalities, rather than biochemical changes. Without going into the detailed
interpretation of these results, which are outside the scope of this paper, we think the observed
differences in the differentially abundant proteins across W1-W5 clusters serve as important
independent confirmation of the distinctiveness of the identified clusters.

Comparison of clusters W1-W5 with our previously published urinary
symptom-based clusters F1-F4
Comparing quality of the clusters. Previously, we identified four clusters (F1-F4) by analyzing data on the same 545 women with LUTS using only urinary symptoms data collected
via the LUTS Tool and AUA-SI (total of 52 variables) [41]. Since the same resampling procedure was performed when generating W1-W5 and F1-F4, both cluster structures are equally
robust to the random variations of the cohort composition.
Distinctiveness, as determined by pairwise comparisons, was higher for the refined clusters
compared with the previously published clusters (Tables 4 and 5). The proportion of significantly different variables in pairwise comparison of the clusters ranged from 27% to 83%
(mean 52%) for the refined clusters, compared with a range of 27% to 58% (mean 43%) for the
Table 5. Proportion of core clusters in W1-W5 and F1-F4.
PCC

PCC

W1

88%

F1

40%

W2

73%

F2

74%

W3

89%

F3

51%

W4

93%

F4

83%

W5

92%

Mean

87%

Mean

62%

https://doi.org/10.1371/journal.pone.0268547.t005
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previous clusters. The proportion of core clusters was also higher for W1-W5, compared with
F1-F4; it ranged from 73% to 93% (mean 87%) for the refined clusters, compared with a range
of 40% to 83% (mean 62%) for the previous clusters. Summarizing, there are more significantly
different variables across refined clusters (W1-W5) than across our previously published clusters (F1-F4), and the refined clusters contain a higher percentage of core members for whom
the probability to be in the given cluster is higher than the probability to be in all other clusters
combined. Therefore, the refined clusters identified in the current paper by using additional
urinary and non-urinary variables (total of 185 variables) are substantially more distinct than
our previously published clusters based only on urinary symptoms measured by the LUTS
Tool and AUA-SI (52 variables).
Comparing cluster membership. The Sankey diagram in Fig 7 serves to compare cluster
membership in W1-W5 and in F1-F4. Refined cluster W1 is mostly composed of the members
of cluster F1 without prolapse. Cluster W2 is formed by the members of cluster F1 with pelvic
organ prolapse and includes some members of other clusters having prolapse and moderate
urinary symptoms. Cluster W3 is mainly composed of members of F2 and F3 with urgency
urinary incontinence. Cluster W4 is predominantly formed by members of F3 with stress urinary incontinence. Cluster W5 includes nearly all members of F4 and approximately 30% of
F3 who have both urgency urinary incontinence and stress urinary incontinence symptoms.
Comparing radar plots. Fig 8 provides comparison of radar plots for the urinary symptom signatures of refined clusters W1-W5 and symptom-based clusters F1-F4. There are substantial similarities in the urinary symptom signatures of our previously published clusters,
and of the refined clusters. Radar plots for W5 and F4 are similar in presenting all urinary
symptoms at a uniformly high level. Signatures of W4 and F3 are similar in presenting the
combination of stress urinary incontinence, urgency, and voiding dysfunction symptoms. W3
and F2 present urinary urgency, urgency urinary incontinence, and mild voiding problems.
Symptom signatures of W1 and F1 are similar, presenting mostly voiding and post-micturition
problems. The signature of cluster W2 presents mild LUTS and is mostly defined by clinically
significant pelvic organ prolapse. The observed similarity of the clusters’ LUTS signatures confirms that additional variables did not result in radical changes, but rather in incremental
changes that allowed for identification of the refined clusters, which are built upon, but are
more distinct and uniform than, our previously published ones. We believe this is further evidence of the stability of the identified clusters. Urinary symptom data captured by the LUTS
Tool and AUA-SI provided the foundation for data-driven subtyping of LUTS, while the
remaining urinary and non-urinary variables allowed for identifying refined clusters that differ
not only by urinary symptoms, but by other PRO, demographic, and clinical variables as well
(Table 3, Figs 5, 6B and 6C). Importantly, cluster refinement enhanced the distinctiveness and
uniformity of the clusters, as well as the confidence in cluster membership, by increasing the
overall proportion of core clusters from 62% to 87%.

Evolution of refined clusters W1-W5 in 3- and 12-month follow-up
Fig 9 presents radar plots of the urinary symptom signatures of refined clusters W1-W5 at 3and 12-month follow-up. As seen, the shapes of the radar plots are conserved, while their areas
representing overall severity of LUTS are decreased due to improvement in urinary symptoms
for some participants. The percentage of improvers varied across the clusters (Table 6).
Improvers were defined as having a ½ SD or greater improvement between baseline and 12
months on the calculated LUTS Tool Summary Score (including all 22 LUTS Tool severity variables). We view stability of the urinary symptom radar plot signatures’ shapes as additional
evidence of robustness of the identified clusters.
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Fig 7. Sankey diagram comparing cluster memberships in W1-W5 and F1-F4. Cluster memberships in the refined cluster W1-W5 and
previously published [41] urinary symptom-based clusters F1-F4 are compared. The new cluster W2 emerged, in which urinary symptoms are
complicated by the presence of anterior vaginal wall prolapse. See text for more details on cluster comparison and properties of refined clusters
W1-W5.
https://doi.org/10.1371/journal.pone.0268547.g007

Potential clinical significance of the identified clusters
The current paradigm for managing patients with LUTS is to assign a diagnosis based on a
pre-defined symptom complex, such as overactive bladder (OAB), or based on a single predominant symptom, such as nocturia or stress urinary incontinence. Treatments are then
administered based on these diagnoses [73,74]. Conventional classification of LUTS includes
such partially overlapping groups as OAB wet, OAB dry, continent, stress urinary incontinence, urgency urinary incontinence, mixed urinary incontinence, underactive bladder, and
bladder outlet obstruction. As stated in [39–41], there are limitations to this paradigm, as
patients frequently present with multiple other urinary symptoms in addition to those being
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Fig 8. Comparison of radar plots of the urinary symptom signatures for clusters W1-W5 and F1-F4. Urinary symptom signatures (shapes of the radar
plots) demonstrate pairwise similarities between the clusters F1-W1, F2-W3, F3-W4, F4-W5.
https://doi.org/10.1371/journal.pone.0268547.g008

treated, and these combinations of symptoms may be relevant to treatment selection. Diagnosis and treatment based solely on patients’ chief complaints may be unsatisfactory, as they disregard other presenting symptoms. Mechanistic studies reveal that a functional impairment to
a specific organ in the urinary tract may cause more than a single symptom. For example, a
weak urethral sphincter is associated with both stress and urgency urinary incontinence
[58,75]. This may explain why mixed incontinence is so common. This raises the question of
how current diagnostic paradigms correspond with biological changes of the continence system and how symptoms occur in women seeking treatment, which was the main rationale for
the unbiased data-driven subtyping of women with LUTS in LURN. As seen, none of the clusters W1-W5 identified in our analysis could be characterized by a single symptom, but rather
by a combination of symptoms with various levels of severity, which are in concert with the
clinical observations mentioned above [58,75]. The more detailed comparison of our refined
clusters W1-W5 with the conventional LUTS groups and subtypes of LUTS identified by other
researchers [36–38,76] is provided in Supplemental Material text in S1 File.

Clustering methodologies reported in studies on subtyping LUTS and
other common diseases and disorders
Previous research on subtyping of diseases and disorders provides various levels of detail
regarding the clustering methodologies that were employed. Below, we provide examples of
high-quality studies using clustering methodologies for subtyping of common complex diseases, disorders, and symptom complexes within and outside of urologic domain. For instance,
Coyne et al [36] provided detailed information on the 14 LUTS questions used for clustering
and indicated that all the variables were scaled from 0 to 1. They took care of the robustness of
clusters to the variation in composition of the cohort by performing clustering on the random
50% subset of participants first, and then by extending it to the whole cohort. They used kmeans algorithm for clustering and scanned the number of clusters K from 3 to 7. They
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Fig 9. Evolution of the urinary symptom signatures in 3- and 12-month follow-up. First row–urinary symptom signatures for members of clusters W1-W5
at 3-month visit. Second row–urinary symptom signatures for members of clusters W1-W5 at 12-month visit. Note that the shape of the radar plots is
conserved (similar to the radar plots in Figs 4 and 8), while the area of the radar plots is decreased due to symptoms improvement in some of the patients
shown in Table 6.
https://doi.org/10.1371/journal.pone.0268547.g009

reported that the decision on the number of clusters was made by evaluating “each cluster
model based on the clinical relevance and distinctiveness of each cluster, as well as the amount
of variance accounted for by the cluster solution.” However, they did not provide the names or
values of criteria used for cluster evaluation. They provided detailed and informative descriptive statistics, but unfortunately, did not provide any tests on significantly different variables in
pairwise comparison of the identified clusters.
Similarly, Hall et al [37] provided detailed information on the 14 LUTS questions and scaling. K-means clustering was performed with random 50% split of the cohort (split-half validation) similar to [36]. Detailed descriptive statistics and omnibus tests are provided across
identified clusters and asymptomatic controls for significant difference in the variables not
used for clustering, including demographics, comorbidities, risk factors, and lifestyle factors.
Table 6. Percentage of improvers in cluster W1-W5 in 12-month follow-up.
Cluster

N patients with 12-month follow-up

N (%) Improvers at 12 months

Cluster W1

50

23 (46%)

Cluster W2

51

23 (45%)

Cluster W3

106

57 (53%)

Cluster W4

70

49 (70%)

Cluster W5

119

69 (58%)

https://doi.org/10.1371/journal.pone.0268547.t006
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However, no information on significant differences in the 14 LUTS variables used for clustering, and no information on pairwise comparison of the clusters is provided. Summarizing,
these two LUTS clustering papers provide a reasonable level of details on scaling of the variables and on the clustering procedure, but unfortunately do not provide enough information
on evaluation of the quality of the identified clusters.
In contrast, Miller et al [38] provided all necessary information on pairwise comparison of
the identified clusters, both for six variables used for clustering, and for eight other variables
collected but not used for clustering. Unfortunately, the authors did not perform any scaling of
variables used for clustering. As stated in the paper, “the six clustering variables were (a) number of voids during daytime hours, (b) number of voids during nighttime hours, (c) daytime
modal output volume in milliliters, (d) total 24-hour output volume in milliliters, (e) total
24-hour beverage intake in milliliters, and (f) BMI (a variable that was speculated to be related
to intake).” If the volumes of related variables c, d, e were not scaled but entered into clustering
in milliliters (values can be as high as 500), then these variables will provide the domineering
contribution (compared with the number of daytime voids, typically < 20) to the 6-dimensional Euclidean distance between clustered objects, and will serve as drivers determining cluster membership. The contribution of these variables to the Euclidean distance would be much
lower if they were entered in liters instead of milliliters, which would change the cluster membership. This is the problem indicated by Hair et al [62], with unscaled, unstandardized data of
the inconsistency between cluster solutions when the scale of some variables is changed, which
is a strong argument in favor of standardization. To our mind, the best solution of the problem
is the use of the variables scaled by comparison with controls, as we described in the Methods
section. Proper scaling is especially important when using heterogeneous data combining
dimensionless and dimensional variables measured in different units, as in [38], where frequencies, volumes (mL), and BMI units (kg/m2) are combined.
A broader look outside the LUTS domain shows that previous data on subtyping other
common complex diseases provide different level of details on the clustering procedure and
cluster evaluation as well. Table 7 below summarizes methodological information reported in
the clustering papers [31–33] subtyping patients with asthma, diabetes, and sepsis, as well as in
the LUTS papers [36–38] discussed above. More details on methodological information
reported in [31–33] are provided in Supplemental Material text in S1 File.

Thoughts on minimal requirements for clustering publications
As shown above, publications using clustering for disease subtyping provide different levels of
details on data preprocessing, clustering procedure, and cluster evaluation. In particular, information on scaling and weighting of the variables, values of criteria used for selection of the
number of clusters, pairwise comparison of the clusters, and level of confidence in cluster
membership are often not provided. This missing or hard-to-find information is important for
better understanding of the papers’ results, for comparison of the proposed phenotypes with
previous and future classifications, and for potential refinement. With this in mind, and
guided by the principles of FAIR data (findability, accessibility, interoperability, and
reusability) [77,78], we think it is time for the clustering community to develop minimum
requirements for clustering reports (MICRo), similar to minimum information about a proteomics experiment (MIAPE), developed by the proteomics community [79], and minimum
information about a microarray experiment (MIAME), developed by the transcriptomics community [80]. We strongly believe that everybody, including the authors of this paper, would
benefit from a collective consensus decision on the minimal information required for clustering publications.
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Table 7. Methodological information provided in the clustering papers.
Paper

Variables

Preprocessing

Clustering algorithm

Number of clusters
determination

Cluster evaluation

Moore
et al [31]

34 variables derived
from initial 726.
Only list of 34
variables provided.

No info on scaling of 17
continuous variables; 17
composite variables ranked
0–10.

Agglomerative hierarchical
clustering, Wards linkage.

Dendrogram demonstrates 5–6
groups. Five clusters selected due
to small size of the sixth group. No
other criteria.

Omnibus tests (analysis of
variance [ANOVA], KruskalWallis, chi-square) used on
demographic, clinical, medication
use, health care utilization, and
biomarker variables. No pairwise
comparisons of clusters.

Ahlqvist
et al [32]

List of six variables
Five variables standardized
used for clustering is as z-scores. Presence of
provided.
glutamic acid decarboxylase
antibodies (GADA) binary
variable.

Patients with GADA
grouped into separate
cluster. K-means with
resampling for patients
without GADA.

Schwarz’s Bayesian criterion to
determine number of clusters
k = 4.

Box plots comparing 5 continuous
variables used for clustering.
Pairwise comparisons of clusters
for multiple variables not used for
clustering. Cluster validation in 3
independent cohorts.

Seymour
et al [33]

List of 29 variables
Variables standardized as z- Resampling-based
used for clustering is scores.
consensus k-means
provided.
clustering.

Consensus matrix heat map. Area
under the CDF curve [34].

Pairwise comparison of variables
clusters for variables used and not
used for clustering. Validation in
an independent cohort.

Coyne
et al [36]

List and description
of 14 EPIC LUTS
questions used for
clustering is
provided.

Variables scaled from 0 to
1.

k-means clustering with
split-half randomization.
Values of k scanned from 3
to 8.

No names or values for criteria
provided.

Descriptive statistics on variables
both used and not used for
clustering, but no tests for
significance.

Hall et al
[37]

List and description
of 14 BACH LUTS
questions used for
clustering is
provided.

Variables scaled from 0 to
1.

Hierarchical clustering and
k-means clustering, splithalf validation.

Pseudo F and t2
statistics were used to determine
number of clusters. However,
values of statistics are not
provided.

Omnibus tests (ANOVA, chisquare) on variables used and not
used for clustering. No pairwise
comparisons of clusters.

Miller
et al [38]

List of six variables
No explicit information on
used for clustering is scaling.
provided.

Agglomerative hierarchical
clustering, Wards linkage.

Dendrogram demonstrates 3–4
groups. Three groups selected
based on visual examination of
separation on canonical variables
plane. No other criteria provided.

Pairwise comparison of clusters
on six variables used for clustering
and 8 variables not used for
clustering. ANOVA for
continuous and chi-square test for
categorical data.

https://doi.org/10.1371/journal.pone.0268547.t007

Exact guidelines for the minimal requirements for clustering publications should result
from the clustering community discussion. Here, we would like to call for such discussion and
propose the below items that we believe are important for future guidelines:
1. Complete list of variables used for clustering.
2. Explicit information on scaling and weighting of clustering variables.
3. Clustering algorithm used (name of the function with options and parameter values, or
code).
4. Exact definition of criteria used to determine the number of clusters. Values of criteria for
the selected and alternative number of clusters. Preferably, more than one criterion should
be presented.
5. Results of pairwise comparison of the clusters, with the indication of clinically meaningful
and significantly different variables in the pairwise comparison–for all variables used
for clustering, and for selected important variables not used for clustering (e.g.,
demographics).
6. Information on the level of confidence in cluster membership.
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Limitations of the current study
Our paper carries some limitations. First, there are limitations in terms of the cohort, which
included only treatment-seeking (e.g., potentially more difficult to treat patients) and predominantly white participants, some of whom (43%) received treatment prior to entering the
study. Our analysis only contains women. Preliminary data analysis confirmed that sex is the
major determinant of LUTS subtypes; therefore, sex-specific clustering was performed. We
previously published the results of urinary symptom-based clustering of male participants
[64]. Cluster refinement of male clusters, along the same lines as described in the current
paper, is underway; the resulting refined subtypes will be compared with those found in the
female cohort. Our control group used for scaling of the variables was relatively small (55 participants) but commensurate with the size of identified clusters. Not all data elements collected
for the cases were available for the controls, so we used some literature data for general population and bladder diary data from a different study (EPI).
Second, there are limitations in terms of data elements used for clustering. Some objective
measures that can be used in the diagnosis of LUTS in women, such as urodynamic testing,
were not available. Urodynamics is clinically indicated in selected, but not all, LUTS patients
due to the invasiveness of the procedure. Genomics data were not used so far. We do not
expect that genomics data will produce dramatic effect on clustering results since LUTS is a
highly prevalent common disease, especially in older age. Nevertheless, genotyping of the
LURN participants is underway, which would allow for future cluster refinement by including
the binary single nucleotide polymorphism (SNP) data using our novel weighted Tanimoto
indices approach. Proteomics data are available for approximately 40% of the cohort and were
not yet used for cluster refinement. However, they were used to demonstrate the presence of
multiple significantly different proteins, indicating the refined symptom-based clusters are
biochemically different.
Third, we developed methodology and a pipeline for integrating heterogeneous continuous
and categorical data for clustering women with LUTS. We cannot claim that this is the preferable methodology for other data sets since data and research questions are different in different
studies. However, we explicitly described our preprocessing and clustering procedures, as well
as criteria used for determination of the number of clusters, cluster evaluation, and confidence
level in cluster membership. We compared our methodology with alternative approaches and
demonstrated that our methodology allows for combining heterogeneous continuous, categorical, and binary data, and that our refined clusters are more distinct than the previous urinary
symptom-based clusters. Detailed description of the methodology, and comparison with the
alternative approaches, allows interested readers to decide if it is suitable for their data and
research questions. Availability of the pipeline source code allows for modifications, if needed.
Fourth, and most importantly, clinical significance of the identified clusters has yet to be
determined. We already demonstrated the distinctness of our clusters, but now we need to
establish their usefulness in clinical practice. This should be done through clinical trials, where
treatments and outcomes of patients classified into the identified clusters would be compared
with the standard treatment without the knowledge of cluster membership. Our preliminary
analysis of 276 serum proteins in women with LUTS corroborated that the identified clusters
are biochemically different. Further analysis of the affected biochemical pathways (potentially
using even more comprehensive targeted proteomics assays, such as Olink Explore [3072 proteins] and/or new SomaScan assay [7000 proteins]), and their longitudinal dynamics as related
to symptom trajectories, will follow with the goal to enhance understanding of different etiologies of the identified subtypes and potentially establishing more effective subtype-specific
treatments. Further research will also include development of a software tool allowing for
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classification of the “real-world” patient into one of the identified subtypes of LUTS and determination of the minimal set of variables sufficient for classification of patients with LUTS into
identified subtypes in clinical practice. We hypothesize that the knowledge of cluster membership for a given patient would help clinicians to select an efficient treatment. This hypothesis
could be tested in a study, where participants are randomized into two groups. The first group
would be treated “as usual”, while the second group would be classified into the identified subtypes of LUTS, with the information provided to the clinicians prescribing treatment. To clarify, we are not suggesting performing such a clinical study immediately. Cluster-specific
treatments are yet to be determined. We believe that identification and further refinement of
the LUTS subtypes with the omics and clinical data will improve our understanding of subtype
etiologies and assist with identification of cause-specific and cluster-specific treatments. At
that point, a clinical trial with cluster-specific treatments would be warranted, even if such
treatments are identified not for all of the subtypes, but for some of them. We view subtyping
not as a panacea, but as an important step in the development of personalized medicine.

Conclusion
A novel clustering pipeline for subtyping of common complex diseases, syndromes, and symptom complexes using heterogeneous continuous and categorical data was developed. The
advantages of scaling variables by comparison with the controls without the disease of interest
were discussed and illustrated by the simulated example. The novel weighted Tanimoto indices
approach to integrate multiple binary variables into the clustering procedure was developed. A
cluster refinement procedure using data available only for the subset of participants through
semi-supervised clustering was proposed. A novel contrast criterion (CC) for resamplingbased consensus clustering was proposed and compared with existing criteria for consensus
clustering, i.e., consensus score (CS) and proportion of ambiguously clustered pairs (PAC). A
simulated example demonstrated the advantages of CC over CS and PAC.
Information provided in the literature on subtyping common complex diseases and disorders was reviewed and shown to be often incomplete, especially with regard to data preprocessing, clustering procedures, and cluster evaluation. Suggestions for the minimum
requirements for clustering publications were formulated, and the community effort to work
on creating such requirements following the principles of FAIR data was called for.
Five distinct clusters of women with LUTS were identified by using 185 variables, including
demographics, physical exam, LUTS and non-LUTS questionnaires, and bladder diary variables. The quality of the clusters was evaluated using established criteria (Calinski-Harabasz,
Davies-Bouldin, Dunn, Point-Biserial, and Silhouette [22–26]), as well as novel contrast criterion (CC) and percentage of core members of the clusters (PCC). Distinctiveness of the clusters was confirmed by multiple significantly different variables in pairwise comparison of the
clusters. Refined clusters W1-W5 were compared with our previously published urinary symptom-based clusters F1-F4, and were shown to be more distinct by having a higher percentage
of significantly different variables and a higher percentage of the core members of the clusters.
Importantly, targeted proteomics data confirmed that our refined clusters based on clinical
data are biochemically different. Identification of the clinically and biochemically distinct subtypes of LUTS has provided a foundation for studies of subtype-specific etiologies and treatments. However, the results of the study should not be overgeneralized. Further refinement of
subtypes is necessary and is coming both from new, more diverse cohorts (e.g., LURN 2 study)
and from this cohort through inclusion of proteomic, genomic (grants ancillary to LURN),
and neuroimaging data. Our paper provides methodology and a pipeline for such refinement
and data integration.
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Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adultonset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018; 6:361–369. https://doi.org/10.1016/S2213-8587(18)30051-2 PMID:
29503172

33.

Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z, et al. Derivation, validation, and
potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019; 321(20):2003–
2017. https://doi.org/10.1001/jama.2019.5791 PMID: 31104070

34.

Monti S, Tamayo P, Meserov J, Golub T. Consensus clustering: A resampling-based method for class
discovery and visualization of gene expression microarray data. Mach Learn 2003; 52:91–118.

35.

Locke K Jr, Lai HH, Pontari MA, Clemens JQ, Kreder KJ, Krieger JN, et al. Discovery, validation, and
novel visualization of subgroups in urologic chronic pelvic pain syndrome (UCPPS): Consensus clustering findings from the MAPP Research Network. J Urol. 2020; 203(4S):e104.

36.

Coyne KS, Matza LS, Kopp ZS, Thompson C, Henry D, Irwin DE, et al. Examining lower urinary tract
symptom constellations using cluster analysis. BJU Int. 2008; 101(10):1267–1273. https://doi.org/10.
1111/j.1464-410X.2008.07598.x PMID: 18336611

37.

Hall SA, Cinar A, Link CL, Kopp ZS, Roehrborn CG, Kaplan SA, et al. Do urological symptoms cluster
among women? Results from the Boston Area Community Health Survey. BJU Int. 2008; 101
(10):1257–1266. https://doi.org/10.1111/j.1464-410X.2008.07557.x PMID: 18419699

38.

Miller JM, Guo Y, Rodseth SB. Diary data subjected to cluster analysis of intake/output/void habits with
resulting clusters compared by continence status, age, race. Nurs Res. 2011; 60(2):115–123.

39.

Yang CC, Weinfurt KP, Merion RM, Kirkali Z, Lurn Study Group. Symptoms of Lower Urinary Tract Dysfunction Research Network. J Urol. 2016; 196(1):146–152. https://doi.org/10.1016/j.juro.2016.01.007
PMID: 26784646

40.

Cameron AP, Lewicky-Gaupp C, Smith AR, Helfand BT, Gore JL, Clemens JQ, et al. Baseline lower urinary tract symptoms in patients enrolled in LURN: a prospective, observational cohort study. J Urol.
2018; 199(4):1023–1031. https://doi.org/10.1016/j.juro.2017.10.035 PMID: 29111381

41.

Andreev VP, Gang L, Yang CC, Smith AR, Helmuth ME, Wiseman JB, et al. Symptom-based clustering
of women in the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) observational cohort study. J Urol. 2018; 200(6):1323–1331. https://doi.org/10.1016/j.juro.2018.06.068 PMID:
29990467

42.

Coyne KS, Sexton CC, Kopp Z, Chapple CR, Kaplan SA, Aiyer LP, et al. Assessing patients’ descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research. Int J Clin Pract. 2010; 64(9):1260–1278. https://doi.org/10.1111/j.1742-1241.2010.
02450.x PMID: 20579138

43.

Coyne KS, Barsdorf AI, Thompson C, Ireland A, Milsom I, Chapple C, et al. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS). Neurourol Urodyn. 2012; 31(4):448–454.
https://doi.org/10.1002/nau.21202 PMID: 22396308

44.

Barry M, Fowler F Jr, O’Leary M, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of
the American Urological Association. J Urol. 1992; 148(5):1549–1557. https://doi.org/10.1016/s00225347(17)36966-5 PMID: 1279218

45.

Cheng J, Leng M, Li L, Zhou H, Chen X. Active semi-supervised community detection based on mustlink and cannot-link constraints. PLoS ONE. 2014; 9(10): e110088. https://doi.org/10.1371/journal.
pone.0110088 PMID: 25329660

46.

Li Z, Liu J, Tang X. Pairwise constraint propagation by semidefinite programming for semi-supervised
classification. Proceedings of the 25th International Conference on Machine Learning; Helsinki, Finland:
2008.

47.

Şenbabaoğlu Y, Michailidis G, Li JZ. Critical limitations of consensus clustering in class discovery. Sci
Rep. 2014; 4:6207. https://doi.org/10.1038/srep06207 PMID: 25158761

48.

Ku JH, Jeong IG, Lim DJ, Byun S, Paick JS, Oh SJ. Voiding diary for the evaluation of urinary incontinence and lower urinary tract symptoms: Prospective assessment of patient compliance and burden.
Neurourol Urodyn. 2004; 23(4):331–335. https://doi.org/10.1002/nau.20027 PMID: 15227650

49.

Spiegel BM, Hays RD, Bolus R, Melmed GY, Chang L, Whitman C, et al. Development of the NIH
Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom
scales. Am J Gastroenterol. 2014; 109(11):1804–1814. https://doi.org/10.1038/ajg.2014.237 PMID:
25199473

PLOS ONE | https://doi.org/10.1371/journal.pone.0268547 June 10, 2022

36 / 38

PLOS ONE

Subtyping complex disorders by clustering heterogeneous data

50.

Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®):
depression, anxiety, and anger. Assessment. 2011; 18(3):263–283. https://doi.org/10.1177/
1073191111411667 PMID: 21697139

51.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;
24(4):385–396. PMID: 6668417

52.

Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, et al. Development of short forms from the
PROMISTM sleep disturbance and sleep-related impairment item banks. Behav Sleep Med. 2011; 10
(1):6–24. https://doi.org/10.1080/15402002.2012.636266 PMID: 22250775

53.

Clemens JQ, Calhoun EA, Litwin MS, McNaughton-Collins M, Kusek JW, Crowley EM, et al. Validation
of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary
pain in both men and women. Urology. 2009; 74(5):983–987. https://doi.org/10.1016/j.urology.2009.06.
078 PMID: 19800663

54.

Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, et al. Further validation of the short form
versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ).
Neurourol Urodyn. 2011; 30(4):541–546. https://doi.org/10.1002/nau.20934 PMID: 21344495

55.

Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of
terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;
175(1):10–17. https://doi.org/10.1016/s0002-9378(96)70243-0 PMID: 8694033

56.

Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index with physical function
as the outcome. J Clin Epidemiol. 2005; 58(6):595–602. https://doi.org/10.1016/j.jclinepi.2004.10.018
PMID: 15878473

57.

Cameron AP, Wiseman JB, Smith AR, Merion RM, Gillespie BW, Bradley CS, et al. Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Network (LURN) cohort. Neurourol Urodyn. 2019; 38(8):2185–2193. https://doi.org/10.1002/nau.24113
PMID: 31347211

58.

DeLancey JO, Fenner DE, Guire K, Patel DA, Howard D, Miller JM. Differences in continence system
between community-dwelling black and white women with and without urinary incontinence in the EPI
study. Am J Obstet Gynecol. 2010; 202(6):584.e1–584.e12. https://doi.org/10.1016/j.ajog.2010.04.027
PMID: 20510959

59.

Benjamini Y, Hochberg Y. Controlling the false discovery rate–a practical and powerful approach to multiple testing. J Royal Statistical Society, Ser B. 1995; 57(1):289–300.

60.

Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P. A multivariate technique for multiply
imputing missing values using a sequence of regression models. Survey Methodol. 2001; 27(1):85–95.

61.

Raghunathan TE, Solenberger PW, Berglund P, Van Hoewyk J. IVEware: Imputation and variance estimation software. Ann Arbor: University of Michigan, Institute for Social Research, Survey Research
Center. 2000.

62.

Hair JR, Anderson RE, Tatham RL, Black WC. Multivariate data analysis. Prentice- Hall Inc: Upper
Saddle River, NJ; 1998.

63.

Andreev VP, Gillespie BW, Helfand BT, Merion RM. Misclassification errors in unsupervised classification methods. Comparison based on the simulation of targeted proteomics data. J Proteomics Bioinform. 2016; S14:005. https://doi.org/10.4172/jpb.S14-005 PMID: 27524871

64.

Liu G, Andreev VP, Helmuth ME, Yang CC, Lai HH, Smith AR, et al. Symptom-based clustering of men
in the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) observational cohort
study. J Urol. 2019; 202(6):1230–1239. https://doi.org/10.1097/JU.0000000000000354 PMID:
31120372

65.

Huang Z. Extensions to the k-means algorithm for clustering large data sets with categorical values.
Data Mining and Knowledge Discovery. 1998; 2(3):283–304.

66.

Ng MK, Li MJ, Huang JZ, He Z. On the impact of dissimilarity measure in k-modes clustering algorithm.
IEEE Transactions on Pattern Analysis and Machine Intelligence. 2007; 29(3):503–507. https://doi.org/
10.1109/TPAMI.2007.53 PMID: 17224620

67.

Szepannek G, Aschenbruck R. k-prototypes clustering for mixed variable-type data. CRAN Repository
2021. Available at: https://cran.r-project.org/web/packages/clustMixType/clustMixType.pdf. Accessed
7/16/21.

68.

SAS clustering action set: Clustering with the k-prototypes algorithm. SAS visual statistics programming
guide. Available at: https://documentation.sas.com/doc/en/pgmsascdc/9.4_3.4/casactstat/casactstat_
clustering_examples06.htm. Accessed 7/16/21.

69.

Rogers DJ, Tanimoto TT. A computer program for classifying plants. Science. 1960; 132(3434):1115–
1118. https://doi.org/10.1126/science.132.3434.1115 PMID: 17790723

PLOS ONE | https://doi.org/10.1371/journal.pone.0268547 June 10, 2022

37 / 38

PLOS ONE

Subtyping complex disorders by clustering heterogeneous data

70.

Bilenko M, Basu S, Mooney RJ. Integrating constraints and metric learning in semi-supervised clustering. Proceedings of the 21st International Conference on Machine Learning (ICML). Banff, Canada.
July 2004. Available at: https://www.cs.utexas.edu/~ml/papers/semi-icml-04.pdf. Accessed 8/6/21.

71.

Huang H, Cheng Y, Zhao R. A semi-supervised clustering algorithm based on must-link set. In Tang C
et al (Eds). ADMA 2008; LNAI 5139:492–499.

72.

Siddiqui NY, Helfand BT, Andreev VP, Kowalski JT, Bradley MS, Lai HH, et al. Biomarkers implicated in
lower urinary tract symptoms: systematic review and pathway analyses. J Urol. 2019; 202(5):880–889.
https://doi.org/10.1097/JU.0000000000000257 PMID: 30925127

73.

Syan R, Brucker BM. Guideline of guidelines: urinary incontinence. BJU International. 2016; 117(1):20–
33. https://doi.org/10.1111/bju.13187 PMID: 26033093

74.

AUA (American Urological Association) Guidelines. Available at: https://www.auanet.org/guidelines.
Accessed 7/22/21.

75.

DeLancey JO, Trowbridge ER, Miller JM, Morgan DM, Guire K, Fenner DE, et al. Stress urinary incontinence: relative importance of urethral support and urethral closure pressure. J Urol. 2008; 179
(6);2286–2290. https://doi.org/10.1016/j.juro.2008.01.098 PMID: 18423707

76.

Rosen RC, Coyne KS, Henry D, Link CL, Cinar A, Aiyer LP, et al. Beyond the cluster: methodological
and clinical implications in the Boston Area Community Health survey and EPIC studies. BJU Int. 2008;
101(10):1274–1278. https://doi.org/10.1111/j.1464-410X.2008.07653.x PMID: 18419700

77.

Go FAIR. FAIR (Findable, Accessible, Interoperable, Reusable) principals for scientific data. Available
at: https://www.go-fair.org/fair-principles/. Accessed 8/18/21.

78.

Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, et al. The FAIR guiding principles for scientific data management and stewardship. Scientific Data. 2016; 3:160018. https://doi.org/
10.1038/sdata.2016.18 PMID: 26978244

79.

Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK Jr., Jones AR, et al. The minimum information
about a proteomics experiment (MIAPE). Nat Biotechnol. 2007; 25(8):887–893. https://doi.org/10.1038/
nbt1329 PMID: 17687369

80.

Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat Genet. 2001;
29(4):365–371. https://doi.org/10.1038/ng1201-365 PMID: 11726920

PLOS ONE | https://doi.org/10.1371/journal.pone.0268547 June 10, 2022

38 / 38

